Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
New JDD Study Introduces Objective Method for Measuring Periorbital Dynamic Lines For dermatology teams focused on antiaging care, this article from the JDD is a must read. Dermatologists and clinical…
ALA PDT for Facial isSCC Shows Complete Histological Clearance in Early Trial Have you read this article from JDD? A study reports striking short term outcomes after two sessions of…
Must-read JDD Letter to the Editor: Pooled analysis finds no significant association between benzoyl peroxide use for acne and risk of hematologic or internal malignancies This JDD “Letter to the…
Rapid Weight Loss and the Skin Patient: What Dermatologists Need to Know For every dermatologist managing postweightloss patients, this JDD review is a must read. A recent narrative review summarizes…
A survey of American adults finds online misinformation is a key factor in sun safety decision- making, including reducing or stopping sunscreen use. Results from the Practice Safe Sun Survey…